TipRanks
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market
ASND
Ascendis Pharma
RESEARCH TOOLSreports
Want to see ASND full AI Analyst Report?

Ascendis Pharma (ASND) Stock News & Sentiment

783 Followers
Ascendis Pharma Reports Five-Year Kidney Function Gains With TransCon PTH in Hypoparathyroidism Trials
Premium
Company Announcements
Ascendis Pharma Reports Five-Year Kidney Function Gains With TransCon PTH in Hypoparathyroidism Trials
5d ago
6K
ASND
Ascendis Pharma: Buy Rating Reiterated as YUVIWEL Outperformance Potential Supports Unchanged $344 Price Target
Premium
Ratings
Ascendis Pharma: Buy Rating Reiterated as YUVIWEL Outperformance Potential Supports Unchanged $344 Price Target
12d ago
ASND
Ascendis Pharma Wins EMA Panel Backing for TransCon CNP in Pediatric Achondroplasia
Premium
Company Announcements
Ascendis Pharma Wins EMA Panel Backing for TransCon CNP in Pediatric Achondroplasia
15d ago
6K
ASND
Ascendis Pharma Grants New Employee Warrants and Updates Articles of Association
Premium
Company Announcements
Ascendis Pharma Grants New Employee Warrants and Updates Articles of Association
17d ago
6K
ASND
Ascendis Pharma: Strong Commercial Momentum Across Yorvipath, Yuviwel, and Skytrofa Drives Buy Rating with Unchanged $304 Price Target
Premium
Ratings
Ascendis Pharma: Strong Commercial Momentum Across Yorvipath, Yuviwel, and Skytrofa Drives Buy Rating with Unchanged $304 Price Target
22d ago
ASND
Ascendis Pharma Closes Warrant Exercise Window, Lifts Share Capital on September 29, 2026
Premium
Company Announcements
Ascendis Pharma Closes Warrant Exercise Window, Lifts Share Capital on September 29, 2026
1M ago
6K
ASND
Ascendis Pharma: Buy Rating Reaffirmed as Analyst Maintains $344 12‑Month Price Target Amid Strategic Upside From TransCon Assets
Premium
Ratings
Ascendis Pharma: Buy Rating Reaffirmed as Analyst Maintains $344 12‑Month Price Target Amid Strategic Upside From TransCon Assets
2M ago
ASND
More ASND News >

ASND News on the Web

Ascendis Pharma price target lowered to $330 from $360 at Citi
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), Ascendis Pharma (ASND) and Amgen (AMGN)
TipRanks News
Bullish
RBC Capital Sticks to Its Buy Rating for Ascendis Pharma (ASND)
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Cytokinetics (CYTK)
TipRanks News
Bullish
RA Capital Management Acquires 1,914,788 Shares of Corbus Pharmaceuticals (CRBP)
GuruFocus News
Neutral
Ascendis Pharma Closes Warrant Exercise Window, Lifts Share Capital on September 29, 2026
TipRanks News
Neutral
Ascendis Pharma Sinks After Novo Nordisk Exit Shock
TipRanks News
Neutral
Ascendis Pharma (ASND) Authorizes $400M Share Buyback
Insider Monkey
Neutral

News Score - Last 7 Days

Very Positive
ASND
Sector Average
Media Buzz
This Week6 articles
Weekly Average6.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ASND’s Media Buzz Sentiment?
6 articles about ASND were published this week. In an average week, 6.75 articles are published.
    What is ASND’s weekly average amount of articles?
    In an average week, 6.75 articles about ASND are published.
      What is ASND’s News Sentiment?
      100% of articles about ASND were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CNCCentene
        GMABGenmab
        LHLabcorp Holdings
        KIDSOrthoPediatrics
        DXCMDexcom
        Showing the stocks with the most bullish news sentiment over the past week